Chronic invasive sinus aspergillosis in immunocompetent hosts: a geographic comparison
- PMID: 20567913
- DOI: 10.1007/s11046-010-9338-x
Chronic invasive sinus aspergillosis in immunocompetent hosts: a geographic comparison
Abstract
Purpose: To investigate potential differences in clinical presentation, histopathology, and outcomes of chronic invasive sinus aspergillosis (CISA) based on geographic region and species of Aspergillus isolated.
Materials and methods: A retrospective analysis of published cases of CISA with a comparison of North American and worldwide cases comprised a systematic search of the English language literature. Thirty-four articles were identified detailing 15 North American and 76 global cases of CISA with cranio-cerebral extension in clinically immunocompetent patients.
Results: North American patients with CISA were older, had a more rapidly progressive course, and appeared to have higher rates of treatment failure and mortality. Anatomic distribution and presenting symptoms were similar between the two groups. North American cases were mostly due to A. fumigatus, while A. flavus was the predominant pathogen worldwide. While granulomatous inflammation was a rare observation in North American cases, it was seen in the majority of cases worldwide. CISA due to A. fumigatus was encountered in older adults, was associated with a chronic inflammatory response, an accelerated clinical course, and a trend toward treatment failure and higher mortality. Patients with A. flavus were younger, demonstrated granulomatous inflammation, and pursued an indolent, clinically responsive course.
Conclusion: Observed differences in clinical presentation, histopathology, and outcome might involve a complex interplay between the human host, Aspergillus species, and local climatic conditions.
Similar articles
-
Indolent invasive sphenoid aspergillosis mimicking a neoplastic process.Histopathology. 2006 Aug;49(2):210-1. doi: 10.1111/j.1365-2559.2006.02388.x. Histopathology. 2006. PMID: 16879405 No abstract available.
-
Orbital aspergillosis in immunocompetent patients.Br J Ophthalmol. 2014 Oct;98(10):1379-84. doi: 10.1136/bjophthalmol-2013-303763. Epub 2014 May 13. Br J Ophthalmol. 2014. PMID: 24825845
-
Granulomatous invasive aspergillosis of paranasal sinuses masquerading as actinomycosis and review of published literature.Mycopathologia. 2014 Apr;177(3-4):179-85. doi: 10.1007/s11046-014-9732-x. Epub 2014 Feb 26. Mycopathologia. 2014. PMID: 24570040 Review.
-
Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.Med Mycol. 2009;47 Suppl 1:S261-70. doi: 10.1080/13693780802247702. Epub 2008 Jul 24. Med Mycol. 2009. PMID: 18654921 Review.
-
Primary mycotic infection of paranasal sinuses.Mycopathologia. 1984 Feb 15;84(2-3):73-6. doi: 10.1007/BF00436515. Mycopathologia. 1984. PMID: 6425695
Cited by
-
"Chronic granulomatous invasive fungal rhinosinusitis associated with SARS-CoV-2 infection: A case report".Ann Med Surg (Lond). 2021 Dec;72:103129. doi: 10.1016/j.amsu.2021.103129. Epub 2021 Dec 2. Ann Med Surg (Lond). 2021. PMID: 34873446 Free PMC article.
-
Fatal Rhinofacial Mycosis Due to Aspergillus nomiae: Case Report and Review of Published Literature.Front Microbiol. 2020 Dec 22;11:595375. doi: 10.3389/fmicb.2020.595375. eCollection 2020. Front Microbiol. 2020. PMID: 33414771 Free PMC article.
-
Marine Bioactive Compounds against Aspergillus fumigatus: Challenges and Future Prospects.Antibiotics (Basel). 2020 Nov 16;9(11):813. doi: 10.3390/antibiotics9110813. Antibiotics (Basel). 2020. PMID: 33207554 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical